Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-avtx
/
Avalo Therapeutics Inc
AVTX
Add to Watchlist
18.840
USD
+1.550
+8.96%
Close 07/02, 13:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
335.87M
Market Cap
Loss
P/E TTM
Avalo Therapeutics Inc
18.840
+1.550
+8.96%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
5.13%
T. Rowe Price Investment Management, Inc.
3.51%
BVF Partners L.P.
3.27%
Nantahala Capital Management, LLC
2.98%
OrbiMed Advisors, LLC
2.87%
Other
82.23%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
5.13%
T. Rowe Price Investment Management, Inc.
3.51%
BVF Partners L.P.
3.27%
Nantahala Capital Management, LLC
2.98%
OrbiMed Advisors, LLC
2.87%
Other
82.23%
Shareholder Types
Shareholders
Proportion
Hedge Fund
25.28%
Investment Advisor
17.19%
Investment Advisor/Hedge Fund
7.29%
Private Equity
3.96%
Research Firm
3.14%
Venture Capital
2.39%
Individual Investor
1.74%
Sovereign Wealth Fund
0.79%
Pension Fund
0.05%
Other
38.18%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
136
24.87M
60.06%
+6.95M
2025Q4
92
15.54M
49.88%
+220.47K
2025Q3
100
15.32M
50.75%
+6.89M
2025Q2
75
7.84M
82.00%
-412.02K
2025Q1
82
8.26M
75.30%
+101.94K
2024Q4
82
7.57M
64.56%
+817.70K
2024Q3
76
6.75M
29.89%
+3.87M
2024Q2
97
946.19K
12.26%
+816.58K
2024Q1
119
129.62K
6.10%
+66.52K
2023Q4
128
65.08K
5.28%
+59.48K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
2.13M
9.33%
+1.91M
+864.97%
Feb 27, 2026
BVF Partners L.P.
1.36M
5.95%
+1.00
+0.00%
Dec 31, 2025
Nantahala Capital Management, LLC
1.24M
5.42%
--
--
Dec 31, 2025
OrbiMed Advisors, LLC
1.19M
5.21%
-162.00K
-12.01%
Dec 31, 2025
UBS Financial Services, Inc.
477.82K
2.1%
+432.61K
+956.93%
Dec 31, 2025
Affinity Asset Advisors LLC
1.05M
4.61%
--
--
Jan 22, 2026
Millennium Management LLC
934.43K
4.1%
+28.63K
+3.16%
Feb 17, 2026
Caligan Partners, LP
881.53K
3.87%
+48.20K
+5.78%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Health Innovation Active ETF
0.07%
iShares Micro-Cap ETF
0.03%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Health Innovation Active ETF
Proportion
0.07%
iShares Micro-Cap ETF
Proportion
0.03%
iShares Core S&P Total U.S. Stock Market ETF
Proportion
0%